• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
7,8-Dihydroxyflavone Hydrate

7,8-Dihydroxyflavone Hydrate

Product ID D3329
Cas No. 38183-03-8
Purity ≥99%
Product Unit SizeCostQuantityStock
25 mg $59.30 In stock
100 mg $84.40 In stock
500 mg $270.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

7,8-Dihydroxyflavone (DHF) is a brain-derived neurotrophic factor (BDNF) mimetic that activates TrkB receptors. DHF displays neuromodulatory, neuroprotective, antipsychotic, anti-obesity, anticancer, antioxidative, anti-inflammatory, and antihypertensive activities. In animal models of traumatic brain injury (TBI), DHF decreases brain edema, neuronal death, and brain tissue damage and improves functional deficits. In animal models of schizophrenia, this compound reverses cognitive deficits and promotes synaptic plasticity. DHF also benefits neurodegenerative disease models such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS); in these models, DHF decreases motor deficits and improves cognitive abilities. DHF prevents the induction of diet-induced obesity in animal models and also decreases adiposity, increases energy expenditure, and improves insulin sensitivity in already-obese animals. In oral squamous cell carcinoma cells, this compound decreases cell growth and induces apoptosis by suppressing Sp1 signaling. DHF also decreases production of NO and PGE2 and suppresses expression of COX-2, iNOS, TNF-α, and IL-1β in LPS-stimulated microglia. In other cellular models, DHF increases levels of HO-1 and Nrf2, protecting against H2O2- and UV light-induced oxidative damage. DHF also increases eNOS expression in vitro and decreases blood pressure in spontaneously hypertensive rats.

Product Info

Cas No.

38183-03-8

Purity

≥99%

Formula

C15H10O4 • xH2O

Formula Wt.

254.24 (anhy)

IUPAC Name

7,8-Dihydroxy-2-phenyl-4H-chromen-4-one

Solubility

DMSO: 24 mg/mL

Appearance

Yellow powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

D3329 MSDS PDF

Info Sheet

D3329 Info Sheet PDF

References

Chan CB, Tse MC, Liu X, et al. Activation of Muscular TrkB by its Small Molecular Agonist 7,8-Dihydroxyflavone Sex-Dependently Regulates Energy Metabolism in Diet-Induced Obese Mice. 2015 Mar 19;22(3):355-68. PMID: 25754472.

Sconce MD, Churchill MJ, Moore C, et al. Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease. Neuroscience. 2015 Apr 2;290:454-71. PMID: 25655214.

Lee RH, Shin JC, Kim KH, et al. Apoptotic effects of 7,8-dihydroxyflavone in human oral squamous cancer cells through suppression of Sp1. Oncol Rep. 2015 Feb;33(2):631-8. PMID: 25434704.

Wu CH, Hung TH, Chen CC, et al. Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling. PLoS One. 2014 Nov 21;9(11):e113397. PMID: 25415296.

Yang YJ, Li YK, Wang W, et al. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia. Pharmacol Biochem Behav. 2014 Jul;122:30-6. PMID: 24662915.

Korkmaz OT, Aytan N, Carreras I, et al. 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis. Neurosci Lett. 2014 Apr 30;566:286-91. PMID: 24637017.

Park HY, Park C, Hwang HJ, et al. 7,8-Dihydroxyflavone attenuates the release of pro-inflammatory mediators and cytokines in lipopolysaccharide-stimulated BV2 microglial cells through the suppression of the NF-κB and MAPK signaling pathways. Int J Mol Med. 2014 Apr;33(4):1027-34. PMID: 24535427.

Ryu MJ, Kang KA, Piao MJ, et al. 7,8-Dihydroxyflavone protects human keratinocytes against oxidative stress-induced cell damage via the ERK and PI3K/Akt-mediated Nrf2/HO-1 signaling pathways. Int J Mol Med. 2014 Apr;33(4):964-70. PMID: 24503931.

Castello NA, Nguyen MH, Tran JD, et al. 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. PLoS One. 2014 Mar 10;9(3):e91453. PMID: 24614170.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • B1879

    Betamethasone Valerate

    Synthetic steroid hormone; glucocorticoid agoni...

    ≥98%
  • P3198

    Phytanic Acid

    Fatty acid metabolite of chlorophyll; RXR and P...

    ≥97%
  • C4402

    Cladribine

    Nucleoside (deoxyadenosine) analog; DNA chain t...

    ≥98%
  • F4583

    Flupirtine Maleate

    Kv7 K+ channel activator, NMDA antagonist, GABA...

    ≥98%
  • N0069

    Naringin

    Flavanone glycoside found in citrus fruit; SERM...

    ≥97%
  • G7240

    GSK-2830371

    Wip1 inhibitor.

    ≥98%
  • D1621

    Deferasirox

    Iron chelator.

    ≥99%
  • A5280

    Angiotensin II (3-8), human

    Endogenous peptide fragment, involved in vasoco...

    ≥95%
  • J3205

    Z-JIB-04

    Jumonji histone demethylase inhibitor.

    ≥98%
  • M1877

    Methylprednisolone

    Synthetic steroid; glucocorticoid agonist.

    ≥96%
  • R8179

    Rutaecarpine, synthetic

    Found in Evodia rutaecarpa; potential cAMP, 3β...

    ≥98%
  • G0247

    2″O-Galloylhyperin

    Flavonoid glycoside found in Pyrola.

    ≥98%
  • P6956

    Prostaglandin E1

    Endogenous prostaglandin, vasodilator.

    ≥98%
  • D1777

    Desmopressin Acetate

    Synthetic peptide, vasopressin derivative; V2 a...

    ≥95%
  • M2400

    MG-132

    Proteasome inhibitor.

    ≥98%
  • P1917

    Phenylethyl 3-methylcaffeate

    Derivative of methyl caffeate, hydroxycinnamic ...

    ≥97%
  • G1310

    GDC-0349

    mTOR inhibitor.

    ≥98%
  • E6995

    Erythromycin Ethylsuccinate

    Macrolide; protein translation inhibitor, mamma...

    ≥97%
  • D1695

    Dexamethasone Phosphate Sodium

    Steroid; glucocorticoid agonist.

    ≥98%
  • L0209

    Lactoferrin, cow

    Endogenous glycoprotein; lactoferrin agonist.

    ≥92%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only